Key details
Phase
Safety & dosing / Large-scale testing
Sponsor
University of Milan
Enrollment target
~34 participants
Primary completion
September 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
4 Years and older
Last updated January 2025